Jewett, A. (2025). First in Human Clinical Study Demonstrating the Safety and Efficacy of NK101 (supercharged NK cells) in the Treatment of Patients with Cancer. South East European Journal of Immunology, 8(CITIM), 040. https://doi.org/10.3889/seejim.2025.6102